Enlarge this image Mylan CEO Heather Bresch defended pricing for the company’s EpiPen on Capitol Hill in September. Pablo Martinez Monsivais/AP hide…
Pharmaceuticals
Pharmaceuticals
-
-
Enlarge this image In an emailed statement, Mylan told NPR, “To date, we know of no evidence that Mylan participated in price…
-
Enlarge this image Fanatic Studio/Getty Images Fanatic Studio/Getty Images The number of doctors who each prescribe millions of dollars of medications annually…
-
Enlarge this image The federal government spends more than $30 billion a year to fund the National Institutes of Health. What changes…
-
Enlarge this image Pfizer’s Celebrex fared well in a safety study that compared the pain reliever with ibuprofen and naproxen. Daniel Acker/Bloomberg…
-
Enlarge this image Generic drugmaker Mylan is one of the companies reported to be the subject of a Justice Department investigation into…
-
Enlarge this image Auvi-Q was pulled from the market in 2015 because of quality concerns. The drug’s maker says the problems have…
-
Enlarge this image WFYI’s Jake Harper reports health stories for Side Effects Public Media in Indianapolis. His newest health anxiety stems from…